170 related articles for article (PubMed ID: 34706740)
1. Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary exercise study.
Brown JT; Kotecha T; Steeden JA; Fontana M; Denton CP; Coghlan JG; Knight DS; Muthurangu V
J Cardiovasc Magn Reson; 2021 Oct; 23(1):118. PubMed ID: 34706740
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance-Augmented Cardiopulmonary Exercise Testing: Comprehensively Assessing Exercise Intolerance in Children With Cardiovascular Disease.
Barber NJ; Ako EO; Kowalik GT; Cheang MH; Pandya B; Steeden JA; Moledina S; Muthurangu V
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940957
[TBL] [Abstract][Full Text] [Related]
3. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis.
Ross L; Costello B; Lindqvist A; Hansen D; Brown Z; Stevens W; Burns A; Prior D; Pianta M; Perera W; La Gerche A; Nikpour M
Semin Arthritis Rheum; 2023 Feb; 58():152137. PubMed ID: 36434894
[TBL] [Abstract][Full Text] [Related]
4. Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension.
Zhao X; Leng S; Tan RS; Chai P; Yeo TJ; Bryant JA; Teo LLS; Fortier MV; Ruan W; Low TT; Ong CC; Zhang S; van der Geest RJ; Allen JC; Hughes M; Garg P; Tan TH; Yip JW; Tan JL; Zhong L
J Cardiovasc Magn Reson; 2022 Dec; 24(1):61. PubMed ID: 36451198
[TBL] [Abstract][Full Text] [Related]
5. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
[TBL] [Abstract][Full Text] [Related]
6. Ongoing Exercise Intolerance Following COVID-19: A Magnetic Resonance-Augmented Cardiopulmonary Exercise Test Study.
Brown JT; Saigal A; Karia N; Patel RK; Razvi Y; Constantinou N; Steeden JA; Mandal S; Kotecha T; Fontana M; Goldring J; Muthurangu V; Knight DS
J Am Heart Assoc; 2022 May; 11(9):e024207. PubMed ID: 35470679
[TBL] [Abstract][Full Text] [Related]
7. Limited Exercise Capacity in Patients with Systemic Sclerosis: Identifying Contributing Factors with Cardiopulmonary Exercise Testing.
Martis N; Queyrel-Moranne V; Launay D; Neviere R; Fuzibet JG; Marquette CH; Leroy S
J Rheumatol; 2018 Jan; 45(1):95-102. PubMed ID: 29093153
[TBL] [Abstract][Full Text] [Related]
8. Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance.
Noguchi A; Kato M; Kono M; Ohmura K; Ohira H; Tsujino I; Oyama-Manabe N; Oku K; Bohgaki T; Horita T; Yasuda S; Nishimura M; Atsumi T
Mod Rheumatol; 2017 May; 27(3):481-488. PubMed ID: 27535805
[TBL] [Abstract][Full Text] [Related]
9. Impaired Exercise Tolerance in Repaired Tetralogy of Fallot Is Associated With Impaired Biventricular Contractile Reserve: An Exercise-Stress Real-Time Cardiovascular Magnetic Resonance Study.
Steinmetz M; Stümpfig T; Seehase M; Schuster A; Kowallick J; Müller M; Unterberg-Buchwald C; Kutty S; Lotz J; Uecker M; Paul T
Circ Cardiovasc Imaging; 2021 Aug; 14(8):e011823. PubMed ID: 34384226
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis.
Dumitrescu D; Nagel C; Kovacs G; Bollmann T; Halank M; Winkler J; Hellmich M; Grünig E; Olschewski H; Ewert R; Rosenkranz S
Heart; 2017 May; 103(10):774-782. PubMed ID: 28062514
[TBL] [Abstract][Full Text] [Related]
11. Distinct cardiovascular phenotypes are associated with prognosis in systemic sclerosis: a cardiovascular magnetic resonance study.
Knight DS; Karia N; Cole AR; Maclean RH; Brown JT; Masi A; Patel RK; Razvi Y; Chacko L; Venneri L; Kotecha T; Martinez-Naharro A; Kellman P; Scott-Russell AM; Schreiber BE; Ong VH; Denton CP; Fontana M; Coghlan JG; Muthurangu V
Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):463-471. PubMed ID: 35775814
[TBL] [Abstract][Full Text] [Related]
12. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
[TBL] [Abstract][Full Text] [Related]
13. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cardiopulmonary exercise test in the prediction of disease progression in systemic sclerosis.
Hemelein RA; Lajkó I; Baráth K; Varga J; Ágoston G; Hulló D; Bocskai M; Dobi D; Rózsavölgyi Z; Milassin Á; Varga A; Somfay A; Kovács L
Clin Exp Rheumatol; 2021; 39 Suppl 131(4):94-102. PubMed ID: 33769261
[TBL] [Abstract][Full Text] [Related]
15. Assessment of left ventricular preload by cardiac magnetic resonance imaging predicts exercise capacity in adult operated tetralogy of Fallot: a retrospective study.
Yap J; Tan JL; Le TT; Gao F; Zhong L; Liew R; Tan SY; Tan RS
BMC Cardiovasc Disord; 2014 Sep; 14():122. PubMed ID: 25245139
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
[TBL] [Abstract][Full Text] [Related]
17. Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study.
Gyllenhammar T; Kanski M; Engblom H; Wuttge DM; Carlsson M; Hesselstrand R; Arheden H
BMC Cardiovasc Disord; 2018 Jan; 18(1):16. PubMed ID: 29382301
[TBL] [Abstract][Full Text] [Related]
18. Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis.
Santaniello A; Casella R; Vicenzi M; Rota I; Montanelli G; De Santis M; Bellocchi C; Lombardi F; Beretta L
Rheumatology (Oxford); 2020 Jul; 59(7):1581-1586. PubMed ID: 31637433
[TBL] [Abstract][Full Text] [Related]
19. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
[TBL] [Abstract][Full Text] [Related]
20. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing.
Dumitrescu D; Oudiz RJ; Karpouzas G; Hovanesyan A; Jayasinghe A; Hansen JE; Rosenkranz S; Wasserman K
PLoS One; 2010 Dec; 5(12):e14293. PubMed ID: 21179195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
